Business Standard

J&J loses $110-million verdict over talc cancer-link claim

There are more than 3,000 lawsuits accusing world's largest health-care company of ignoring studies

Johnson & Johnson
Premium

Johnson & Johnson <b>(Image: Reuters)</b>

Margaret Cronin FiskTim Bross
Johnson & Johnson was ordered by a St. Louis jury to pay more than $110 million to a Virginia woman who blamed her ovarian cancer on the company’s talcum products.
 
Imerys Talc America, which provided the talc to J&J, was ordered by the jury to pay about $100,000. Imerys Talc is a unit of Paris-based Imerys SA.
 
There are more than 3,000 lawsuits accusing the world’s largest health-care company of ignoring studies linking its baby powder and Shower to Shower talc products to ovarian cancer and failing to warn customers about the risk.

J&J lost jury verdicts

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in